Archive 2021 and earlier
First Annual General Meeting of Galenica Ltd.
Press release, Wednesday, 9 May 2018
Annual results of the Galenica Group 2017
Press release, Tuesday, 13 March 2018
2017 sales of the Galenica Group
Press release, Thursday, 18 January 2018
Galenica Group half year results 2017
Press release, Tuesday, 8 August 2017
Daniele Madonna to become new Head Retail Business sector
Press release, Wednesday, 7 June 2017
Galenica locks in mid- and long-term financing at attractive conditions with the issuance of bonds
Press release, Tuesday, 30 May 2017
Galenica Santé IPO - Full exercise of over-allotment option
Press release, Wednesday, 12 April 2017
Galenica Santé lists on SIX Swiss Exchange
Press release, Friday, 7 April 2017
IPO Galenica Santé: Galenica announces narrowed price range and upsizing of the IPO
Press release, Monday, 3 April 2017
Galenica launches IPO of Galenica Santé and sets price range
Press release, Friday, 24 March 2017
Advance information IPO of Galenica Santé
Press release, Friday, 24 March 2017
COMCO ruling against HCI Solutions Ltd.
Press release, Monday, 20 March 2017
Galenica announces plans for IPO of Galenica Santé on SIX Swiss Exchange
Press release, Tuesday, 14 March 2017
Strategy of the Galenica Group: Milestone 2020
Press release, Tuesday, 14 March 2017
Results of the Galenica Group 2016
Press release, Tuesday, 14 March 2017
Galenica Santé adds Merfen® and Vita-Merfen® to its OTC product portfolio
Press release, Wednesday, 22 February 2017
Planned division of the Galenica Group
Press release, Thursday, 19 January 2017
2016 sales of the Galenica Group
Press release, Thursday, 19 January 2017
Galenica strengthens its logistics business
Press release, Wednesday, 11 January 2017
Change to the shareholder structure of the Galenica Group
Press release, Monday, 9 January 2017
Vifor Pharma and ChemoCentryx announce expansion of Kidney Health Alliance to include CCX140 to treat renal diseases
Press release, Thursday, 22 December 2016
Swisscom Health to take over Galenica practice information system
Press release, Thursday, 8 December 2016
FDA Approves Supplemental New Drug Application for Veltassa® Removing Boxed Warning Regarding Drug-Drug Interactions
Press release, Sunday, 27 November 2016
New management at Vifor Pharma and new Galenica Group CFO designated
Press release, Wednesday, 5 October 2016
Galenica completes acquisition of Relypsa
Press release, Thursday, 1 September 2016
Contact
Galenica Ltd.
3027 Bern
Tel. +41 58 852 85 17
Mobile +41 79 371 77 24
Fax +41 58 852 85 58